SEARCH

SEARCH BY CITATION

References

  • Alasfoor, K. , Alrasheed, M. , Alsayegh, F. & Mousa, S.A. (2009) Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP). Annals of Hematology, 88, 239243.
  • Arnold, D.M. , Dentali, F. , Crowther, M.A. , Meyer, R.M. , Cook, R.J. , Sigouin, C. , Fraser, G.A. , Lim, W. & Kelton, J.G. (2007) Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Annals of Internal Medicine, 146, 2533.
  • Audia, S. , Lakomy, D. , Guy, J. , Leguy-Seguin, V. , Berthier, S. , Aho, S. , Lorcerie, B. & Bonnotte, B. (2010) Treatment of immune thrombocytopenia: a retrospective study of 40 patients. La Revue De Médecine Interne, 31, 337344.
  • Badar, T. , Ziauddin, S. , Albeirouti, B. , Abdelhameed, A. & Al-Humaidi, A. (2010) Efficacy of early use of rituximab in steroid refractory severe immune thrombocytopenic purpura in adult patients: single institution experience from Saudi Arabia. Blood (ASH Annual Meeting Abstracts), 116, 4681.
  • Berger, J.R. , Houff, S.A. & Major, E.O. (2009) Monoclonal antibodies and progressive multifocal leukoencephalopathy. mAbs, 1, 583589.
  • Carson, K.R. & Bennett, C.L. (2009) Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating. Leukemia & Lymphoma, 50, 323324.
  • Carson, K.R. , Evens, A.M. , Richey, E.A. , Habermann, T.M. , Focosi, D. , Seymour, J.F. , Laubach, J. , Bawn, S.D. , Gordon, L.I. , Winter, J.N. , Furman, R.R. , Vose, J.M. , Zelenetz, A.D. , Mamtani, R. , Raisch, D.W. , Dorshimer, G.W. , Rosen, S.T. , Muro, K. , Gottardi-Littell, N.R. , Talley, R.L. , Sartor, O. , Green, D. , Major, E.O. & Bennett, C.L. (2009) Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood, 113, 48344840.
  • Cines, D.B. & Blanchette, V.S. (2002) Immune thrombocytopenic purpura. The New England Journal of Medicine, 346, 9951008.
  • Clausen, M.R. , Segel, E. , Brandsborg, M. & d'Amore, F. (2011) Very long-term remission induced by short-term rituximab monotherapy in a patient with heavily pretreated, chronic immune thrombocytopenic purpura. European Journal of Haematology, 86, 256259.
  • Conde García, M.C. , Fernández Feijoo, M.A. & Calleja Hernández, M.A. (2009) Study of rituximab efficacy, cost, safety, and compliance of its package leaflet in a tertiary hospital]. Farmacia Hospitalaria: Órgano Oficial De Expresión Científica De La Sociedad Española De Farmacia Hospitalaria, 33, 305311.
  • Cooper, N. , Stasi, R. , Cunningham-Rundles, S. , Feuerstein, M.A. , Leonard, J.P. , Amadori, S. & Bussel, J.B. (2004) The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. British Journal of Haematology, 125, 232239.
  • Cooper, N. , Evangelista, M.L. , Amadori, S. & Stasi, R. (2007) Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura? Current Opinion in Hematology, 14, 642646.
  • Dolan, J.P. , Sheppard, B.C. & DeLoughery, T.G. (2008) Splenectomy for immune thrombocytopenic purpura: surgery for the 21st century. American Journal of Hematology, 83, 9396.
  • Duval, S. & Tweedie, R. (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56, 455463.
  • Egger, M. , Davey Smith, G. , Schneider, M. & Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.), 315, 629634.
  • Garcia-Chavez, J. , Majluf-Cruz, A. , Montiel-Cervantes, L. , Esparza, M.G. , Vela-Ojeda, J. & Mexican Hematology Study Group (2007) Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis. Annals of Hematology, 86, 871877.
  • Godeau, B. , Porcher, R. , Fain, O. , Lefrère, F. , Fenaux, P. , Cheze, S. , Vekhoff, A. , Chauveheid, M.P. , Stirnemann, J. , Galicier, L. , Bourgeois, E. , Haiat, S. , Varet, B. , Leporrier, M. , Papo, T. , Khellaf, M. , Michel, M. & Bierling, P. (2008) Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood, 112, 9991004.
  • Hasan, A. , Michel, M. , Patel, V. , Stasi, R. , Cunningham-Rundles, S. , Leonard, J.P. & Bussel, J. (2009) Repeated courses of rituximab in chronic ITP: three different regimens. American Journal of Hematology, 84, 661665.
  • Higgins, J.P.T. & Thompson, S.G. (2002) Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21, 15391558.
  • Higgins, J.P. , Thompson, S.G. , Deeks, J.J. & Altman, D.G. (2003) Measuring inconsistency in meta-analyses. BMJ (Clinical Research Ed.), 327, 557560.
  • Kojouri, K. , Vesely, S.K. , Terrell, D.R. & George, J.N. (2004) Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood, 104, 26232634.
  • Li, Z. , Mou, W. , Lu, G. , Cao, J. , He, X. , Pan, X. & Xu, K. (2011) Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia. International Journal of Hematology, 93, 9198.
  • Mazzucconi, M.G. , Arista, M.C. , Peraino, M. , Chistolini, A. , Felici, C. , Francavilla, V. , Macale, E. , Conti, L. & Gandolfo, G.M. (1999) Long-term follow-up of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy. European Journal of Haematology, 62, 219222.
  • Medeot, M. , Zaja, F. , Vianelli, N. , Battista, M. , Baccarini, M. , Patriarca, F. , Soldano, F. , Isola, M. , De Luca, S. & Fanin, R. (2008) Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results. European Journal of Haematology, 81, 165169.
  • Moher, D. , Liberati, A. , Tetzlaff, J. , Altman, D.G. & PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical Epidemiology, 62, 10061012.
  • Narat, S. , Gandla, J. , Hoffbrand, A.V. , Hughes, R.G. & Mehta, A.B. (2005) Rituximab in the treatment of refractory autoimmune cytopenias in adults. Haematologica, 90, 12731274.
  • Neunert, C. , Lim, W. , Crowther, M. , Cohen, A. , Solberg, Jr, L. , Crowther, M.A. & American Society of Hematology (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood, 117, 41904207.
  • Peñalver, F.J. , Jiménez-Yuste, V. , Almagro, M. , Alvarez-Larrán, A. , Rodríguez, L. , Casado, M. , Gallur, L. , Giraldo, P. , Hernández, R. , Menor, D. , Rodríguez, M.J. , Caballero, D. , González, R. , Mayans, J. , Millán, I. , Cabrera, J.R. & Multi-institutional Retrospective Spanish Study Group on the Use of Rituximab in Refractory ITP (2006) Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients. Annals of Hematology, 85, 400406.
  • Provan, D. , Butler, T. , Evangelista, M.L. , Amadori, S. , Newland, A.C. & Stasi, R. (2007) Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults. Haematologica, 92, 16951698.
  • Provan, D. , Stasi, R. , Newland, A.C. , Blanchette, V.S. , Bolton-Maggs, P. , Bussel, J.B. , Chong, B.H. , Cines, D.B. , Gernsheimer, T.B. , Godeau, B. , Grainger, J. , Greer, I. , Hunt, B.J. , Imbach, P.A. , Lyons, G. , McMillan, R. , Rodeghiero, F. , Sanz, M.A. , Tarantino, M. , Watson, S. , Young, J. & Kuter, D.J. (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 115, 168186.
  • Robak, T. (2004) Monoclonal antibodies in the treatment of autoimmune cytopenias. European Journal of Haematology, 72, 7988.
  • Rodeghiero, F. , Stasi, R. , Gernsheimer, T. , Michel, M. , Provan, D. , Arnold, D.M. , Bussel, J.B. , Cines, D.B. , Chong, B.H. , Cooper, N. , Godeau, B. , Lechner, K. , Mazzucconi, M.G. , McMillan, R. , Sanz, M.A. , Imbach, P. , Blanchette, V. , Kühne, T. , Ruggeri, M. & George, J.N. (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood, 113, 23862393.
  • Sailler, L. (2008) Rituximab off label use for difficult-to-treat auto-immune diseases: reappraisal of benefits and risks. Clinical Reviews in Allergy & Immunology, 34, 103110.
  • Saleh, M.N. , Gutheil, J. , Moore, M. , Bunch, P.W. , Butler, J. , Kunkel, L. , Grillo-López, A.J. & LoBuglio, A.F. (2000) A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia. Seminars in Oncology, 27 (Suppl 12), 99103.
  • Schwartz, J. , Leber, M.D. , Gillis, S. , Giunta, A. , Eldor, A. & Bussel, J.B. (2003) Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). American Journal of Hematology, 72, 9498.
  • Schweizer, C. , Reu, F.J. , Ho, A.D. & Hensel, M. (2007) Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Annals of Hematology, 86, 711717.
  • Stasi, R. , Pagano, A. , Stipa, E. & Amadori, S. (2001) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood, 98, 952957.
  • Stasi, R. , Stipa, E. , Forte, V. , Meo, P. & Amadori, S. (2002) Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura. Blood, 99, 38723873.
  • Stasi, R. , Cooper, N. , Del Poeta, G. , Stipa, E. , Evangelista, M.L. , Abruzzese, E. & Amadori, S. (2008) Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell–depleting therapy with rituximab. Blood, 112, 11471150.
  • Stasi, R. , Newland, A. , Thornton, P. & Pabinger, I. (2010) Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate Annals of Hematology, 89, 11851195.
  • Stroup, D.F. , Berlin, J.A. , Morton, S.C. , Olkin, I. , Williamson, G.D. , Rennie, D. , Moher, D. , Becker, B.J. , Sipe, T.A. & Thacker, S.B. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA: The Journal of the American Medical Association, 283, 20082012.
  • Vianelli, N. , Galli, M. , de Vivo, A. , Intermesoli, T. , Giannini, B. , Mazzuconi, M. , Barbui, T. , Tura, S. & Baccaranion, M. (2005) Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica, 90, 7277.
  • Zaja, F. , Vianelli, N. , Sperotto, A. , De Vita, S. , Iacona, I. , Zaccaria, A. , Masolini, P. , Tomadini, V. , Tani, M. , Molinari, A.L. , Baccarani, M. & Fanin, R. (2003) B-cell compartment as the selective target for the treatment of immune thrombocytopenias. Haematologica, 88, 538546.
  • Zaja, F. , Baccarani, M. , Mazza, P. , Bocchia, M. , Gugliotta, L. , Zaccaria, A. , Vianelli, N. , Defina, M. , Tieghi, A. , Amadori, S. , Campagna, S. , Ferrara, F. , Angelucci, E. , Usala, E. , Cantoni, S. , Visani, G. , Fornaro, A. , Rizzi, R. , De Stefano, V. , Casulli, F. , Battista, M.L. , Isola, M. , Soldano, F. , Gamba, E. & Fanin, R. (2010) Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood, 115, 27552762.
  • Zwaginga, J. , Van der Holt, R. , Biemond, B. , te Boekhorst, P. , Levin, M. , Vreughdenhil, A. , Huijgens, P.C. , Brand, A. , van der Griend, R. , Luten, M. , Pruijt, H. , de Weerdt, O. , van Pampus, E. , Zweegman, S. , Hollestein, R. & Koene, H. (2010) Interim analysis on a Dutch HOVON multicenter randomised open label phase II trial on 3 rituximab dosing schemes in chronic ITP patients. Blood (ASH) Annual Meeting Abstracts, 116, 2514.